Physician profile
Diana Trease
NPI 1578002481
$3,084.43
in general payments reported to CMS, 2019-2025
18 companies · $898 in 2025
The $898 reported for 2025 was more than what 83% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $394 · 2023: $656 · 2024: $825 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,325 · Education: $53.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,324.84 |
| Education | $53.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $580.36 | 2024-2025 | |
| Daiichi Sankyo INC. | $375.38 | 2022-2024 | |
| Incyte Corporation | $311.37 | 2021 | |
| Lilly USA, LLC | $289.06 | 2023-2024 | |
| Abbvie INC. | $272.08 | 2023-2025 | |
| Syndax Pharmaceuticals, INC. | $139.40 | 2025 | |
| Sobi, INC | $122.18 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $115.90 | 2022 | |
| Pharmacosmos Therapeutics INC. | $108.41 | 2025 | Monoferric |
| Merck Sharp & Dohme LLC | $104.00 | 2025 | Welireg |
| Beigene USA, INC. | $101.62 | 2022 | |
| Gilead Sciences, INC. | $100.29 | 2024 | Trodelvy |
| Kite Pharma, INC. | $96.44 | 2023 | Yescarta |
| Regeneron Healthcare Solutions, INC. | $88.90 | 2023 | Libtayo |
| Beone Medicines USA, INC. | $82.10 | 2025 | Brukinsa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.94 | 2024 | |
| Dendreon Pharmaceuticals LLC | $65.01 | 2023 | Provenge |
| Takeda Pharmaceuticals U.S.A., INC. | $53.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Trease listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.